Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities
Publication date
2020-06
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Type 2 diabetes and cognitive dysfunction are highly prevalent disorders worldwide. Although type 2 diabetes is associated with an increased risk of dementia, awareness of the link between the two conditions is poor, and few recommendations are available to guide clinicians about how to approach cognitive dysfunction in people with diabetes. Clinical guidelines in diabetes have only recently begun to emphasise the importance of cognitive impairment in diabetes and its management. This Series paper aims to synthesise knowledge about the link between diabetes and cognitive dysfunction, issues pertaining to screening and diagnosis of cognitive impairment and dementia in those with type 2 diabetes, management of diabetes in people with cognitive dysfunction (accounting for age and frailty), and emerging therapies for prevention. A conceptual framework for approaching screening and diagnosis is included, and future research directions to guide the field forward are suggested.
Keywords
Taverne, Endocrinology, Internal Medicine, Endocrinology, Diabetes and Metabolism, Review, Journal Article
Citation
Srikanth, V, Sinclair, A J, Hill-Briggs, F, Moran, C & Biessels, G J 2020, 'Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities', The Lancet Diabetes & Endocrinology, vol. 8, no. 6, pp. 535-545. https://doi.org/10.1016/S2213-8587(20)30118-2